Discontinuation of M6 Product Lines and Held-for-Sale Assets (Tables)

3 Months Ended

Mar. 31, 2025

Discontinuation of Product Line and Held for Sale Assets [Abstract]

Summary of Impairment Charges

A summary of impairment charges recognized during the three months ended March 31, 2025, and the associated financial statement lines in which such costs are recognized is shown in the table below. All such charges are included within the Company’s Global Spine reporting segment.

(Unaudited, U.S. Dollars, in thousands)	Financial Statement Line Item	Three Months Ended March 31,2025
Inventory reserve charges	Cost of sales	$	8,703
Impairment of property, plant, and equipment	Operating expenses		6,226
Impairment of developed technology intangible asset	Acquisition-related amortization, impairment, and remeasurement		14,097
Loss on M6 inventories and long-lived assets held for sale		$	29,026

Summary of Assets and Liabilities Associated with M6 Product Line Classified as Held for Sale

In addition, significant classes of assets and liabilities associated with the M6 product lines, which is classified as held for sale, are shown in the table below:

(Unaudited, U.S. Dollars, in thousands)	March 31, 2025
Inventories	$	3,929
Property, plant, and equipment, net		—
Intangible assets, net		—
Net carrying value of disposal group	$	3,929